DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "MEA Parenteral Nutrition Market Analysis By Type of Nutrition (Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals), By Dosage Form, By Region, And Segment Forecasts, 2014 - 2025" report to their offering.
The MEA parenteral nutrition market is expected to reach USD 377.1 million by 2025
The MEA parenteral nutrition market is expected to witness lucrative growth over the forecast period owing to various parameters such as presence of large pool of malnourished children, rising premature births, increasing adoption by healthcare settings for nutrient administration in chronically ill geriatric patients, and rising prevalence rate of cancer within the region.
Increasing prevalence of chronic conditions such as cancer unswervingly influences the use of parenteral nutrition across the globe. Parenteral nutrition helps in the administration of key vital nutrients that are useful in maintaining strength, energy, and hydration level in cancer patients, thus, acting a vital impact rendering driver expected to surge market growth over the forecast period.
Similarly, predominant existence of malnourished children and premature neonates that require these nutrients, is expected to further propel the growth. According to statistics published by the Knoema, a public data platform, the prevalence of the malnutrition in Middle East and North Africa in 2013 was around 6.04%, however, it has witnessed a decline over the period of time.
Key Topics Covered:
1. Methodology and Scope
2. Executive Summary
3. MEA Parenteral Nutrition Market Variables, Trends & Scope
4. MEA Parenteral Nutrition: Nutrient Type Estimates & Trend Analysis
5. MEA Parenteral Nutrition: Dosage Form Estimates & Trend Analysis
6. MEA Parenteral Nutrition: Regional Estimates & Trend Analysis
7. Competitive Landscape
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Pfizer, Inc. (Hospira)
- Otsuka Pharmaceutical Factory, Inc.
- Qatar Pharma Factory
- Pharmaceutical Solutions Industry
- Kuwait Saudi Pharmaceutical Industries Co.
- Alfa Laboratories
- Well Pharma
- SP S.A.R.L (Serum Product Group)
For more information about this report visit https://www.researchandmarkets.com/research/brhc59/mea_parenteral